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Background: A hydrophobic fusion peptide (FP) helps promote paramyxovirus F-mediated membrane fusion.
Results: Efficient membrane disordering and cell-cell fusion strongly correlate with the -helical character of the Hendra F FP.
Conclusion: The FP adopts an -helical structure during membrane fusion.
Significance: This study represents the first in-depth characterization of a paramyxovirus FP and offers new mechanistic
insights into F-mediated fusion.
Viral fusion proteins are intriguing molecular machines that
undergo drastic conformational changes to facilitate virus-cell
membrane fusion. During fusion a hydrophobic region of the
protein, termed the fusion peptide (FP), is inserted into the tar-
get host cell membrane, with subsequent conformational
changes culminating in membrane merger. Class I fusion pro-
teins contain FPs between 20 and 30 amino acids in length that
are highly conserved within viral families but not between. To
examine the sequence dependence of the Hendra virus (HeV)
fusion (F) protein FP, the first eight amino acids were mutated
first as double, then single, alanine mutants. Mutation of highly
conserved glycine residues resulted in inefficient F protein
expression and processing, whereas substitution of valine resi-
dues resulted in hypofusogenic F proteins despite wild-type sur-
face expression levels. Synthetic peptides corresponding to a
portion of the HeV F FP were shown to adopt an -helical sec-
ondary structure in dodecylphosphocholine micelles and small
unilamellar vesicles using circular dichroism spectroscopy.
Interestingly, peptides containing point mutations that pro-
mote lower levels of cell-cell fusion within the context of the
whole F protein were less -helical and induced less membrane
disorder in model membranes. These data represent the first
extensive structure-function relationship of any paramyxovirus
FP and demonstrate that the HeV F FP and potentially other
paramyxovirus FPs likely require an -helical structure for effi-
cient membrane disordering and fusion.
Paramyxoviruses represent a significant threat to human
health and include well established pathogens such as measles,
mumps, and respiratory syncytial virus in addition to the Hen-
dra (HeV)2 and Nipah (NiV) viruses (1, 2). HeV and NiV are
highly pathogenic zoonotic viruses that were identified in 1994
and 1999, respectively, as the etiological agents responsible for
cases of severe respiratory disease and encephalitis in Australia
and Malaysia (2–5). High mortality rates coupled with sus-
pected human-to-human transmission has resulted in both
HeV and NiV being classified as biosafety level four (BSL-4)
pathogens as well as NIAID category C priority pathogens.
Understanding key points within the viral lifecycle is, therefore,
vital for the development of antiviral therapeutics.
Fusion between the viral and cellular membranes is essential
for paramyxovirus infection, as it culminates in the deposition
of the viral genome into the target cell. Generally, paramyxovi-
rus-promoted membrane fusion requires the concerted effort
of two viral surface glycoproteins (with the notable exception of
Pneumovirinae subfamily members): the attachment protein
(H, HN, or G), which mediates initial receptor binding, and the
fusion (F) protein, which drives membrane merger through a
series of extensive conformational changes (6). All paramyxo-
virus F proteins are trimeric type-I integral membrane proteins
and, like other class I fusion proteins, contain several regions
critical for fusion promotion (Fig. 1A) including a hydrophobic
N-terminal fusion peptide (FP), two heptad repeat (HR) regions
(HRA and HRB), and a C-terminal transmembrane domain
(TMD). Following proteolytic cleavage, the metastable F pro-
tein must be triggered to undergo the vast conformational
changes required for membrane fusion. Though the specific
mechanism of triggering remains poorly understood, it facili-
tates extension ofHRA toward, and FP insertion into, the target
cell membrane (7–9). Fusion peptide insertion physically links
both the viral and cellular membranes together, coupling the
force generated by F rearrangement to membrane merger (10).
Subsequent conformational changes position HRA andHRB in
close proximity, culminating in the formation of a stable six-
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helix bundle and fusion pore formation (11). Despite the exist-
ence of pre- and post-fusion structures for someparamyxovirus
F proteins (12, 13), key structural details regarding fusion inter-
mediates remain elusive, including exactly how the FP helps
drive fusion.
Fusion peptides of class I fusion proteins are highly con-
served within viral families, but not between viral families (Fig.
1B). On average, FPs are 20 to 30 amino acids in length and are
particularly enriched in glycine and alanine residues (Fig. 1C),
likely rendering these regions remarkably flexible and, in the
case of isolated peptides, structurally polymorphic (14, 15).
Such conformational flexibility may well be needed to promote
the membrane perturbation needed for fusion (10). Studies
from disparate viral systems including influenza HA (16–19),
HIV Env (20–24), Sendai F (25) and Ebola GP (26) have used
synthetic peptides corresponding to the FP (or fusion loop in
the case of Ebola GP) to perform structure-function experi-
ments, and to complementmutational studies within thewhole
protein. The influenza HA FP seems to require substantial
-helical character for membrane fusion (16, 17, 27), and is
thought to adopt a kinked “boomerang” structure which is vital
for membrane fusion promotion (17, 27). Despite the availabil-
ity of structural data for both HIV Env (28, 29) and influenza
HA (17, 18, 30) FPs, similar structural studies have not been
performed for any paramyxovirus FP to date.
Previous work examining paramyxovirus FPs has focused on
the highly conserved glycine residues (31–34).Workwith para-
influenza virus 5 (PIV5) F demonstrated that mutation of three
N-terminal glycine residues (G3, G7, and G12, as named in Ref.
32) dramatically increased membrane fusion while decreasing
the requirement for the homotypic attachment protein, sug-
gesting that these residues were critical in pre-fusion F protein
stability (32). Conversely, similar mutations in Newcastle dis-
ease virus (NDV) F and human parainfluenza virus 3 (HPIV3) F
led to moderate increases and, in the case of the G7 mutant of
NDV F, decreases in membrane fusion (32), with no change in
the requirement for an attachment protein.
To examine the sequence requirements of the Hendra F FP,
double and single alanine mutations were introduced into the
first eight residues of the FP. Mutation of glycine residues
within the FP to alanine significantly decreased F protein
expression and processing, whereas the VM114/115AA double
mutation completely abolished fusion. Circular dichroism
spectra of synthetic fusion peptides demonstrated a strong cor-
relation between peptide -helicity in micelles, cell-cell fusion
levels, and the degree of membrane disordering suggesting that
the HeV F protein FP requires an -helical structure for func-
tion. Together, these data demonstrate that the combination of
at least two single alanine mutations within the FP can lead to
dramatic fusion defects, whereas any single mutation is better
tolerated. Additionally, these data point toward a role for valine
residues in F-promoted fusion, whereasN-terminal glycine res-
idues are important for efficient expression and processing of
HeV F.
EXPERIMENTAL PROCEDURES
Cell Lines and Culture—Vero and BSR cells (provided by
Karl-Klaus Conzelman, Pettenkofer Institut) were maintained
inDulbecco’smodified Eagle’smedia (DMEM; Invitrogen) sup-
plemented with 10% fetal bovine serum and 1% penicillin and
streptomycin. To select for T7 polymerase-expressing cells, 0.5
mg/mlG-418 sulfate (Invitrogen) was added to themedia of the
BSR cells every third passage.
Plasmids and Antibodies—Plasmids containing Hendra F
and G were generously provided by Dr. Lin-Fa Wang (Austra-
lian Animal Health Laboratory). All Hendra F mutants were
made in pGEM using the QuikChange site-directed mutagen-
esis kit (Stratagene) and subcloned into pCAGGS as described
previously (35). Resultant constructs were sequenced in their
entirety to confirm sequence integrity. Anti-peptide antibodies
to residues 527–539 of the Hendra F cytoplasmic tail (35) were
used to pull down F.
Syncytia Assay—Vero cells in 6-well plates (90% confluent)
were transiently transfected with pCAGGS-Hendra F (0.5 g)
FIGURE 1. Amino acid composition of fusion peptides from class I fusion
proteins.A, shown is adiagramof aparamyxovirus Fprotein in theuncleaved
(F0) and cleaved, fusogenically active F1F2 forms. HR, heptad repeat; CTD,
C-terminal domain (C-tail); * denotes site of proteolytic cleavage. B, shown is
alignment of paramyxovirus fusion peptides with completely conserved
amino acids shaded and compared with fusion peptides from influenza HA
and HIV Env. References for sequences are as follows: Hendra (5), PIV5 (59),
measles (60), NDV (61), Mumps (62), Sendai (63), HPIV1 (humanparainfluenza
virus type 1 (64)), CDV (canine distemper virus (65)), influenza (66), HIV (22).
C, percent alanine andglycine composition of the fusion peptides is shown in
B as compared with the whole protein.
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and pCAGGS-Hendra G (1.5g) using Lipofectamine and Plus
Reagent (Invitrogen) permanufacturer’s protocol. Syncytia for-
mation was observed 24- to 48-h post-transfection, and photo-
graphswere taken using aNikon digital cameramounted atop a
Nikon TS100 microscope with a 10 objective.
Surface Biotinylation of Wild-type and Mutant Proteins—
Sub-confluent Vero cells (80–90%) in 60-mmdishes were tran-
siently transfected using Lipofectamine and Plus reagent (3 g
of DNAwild-type or mutant pCAGGS-Hendra F) according to
the manufacturer’s protocol. Eighteen to twenty-four hours
post-transfection, cells were washed with PBS and starved for
45 min in DMEM deficient in cysteine and methionine. Cells
were then labeled for 3 h with DMEM deficient in cysteine and
methionine containing Tran35S-label (100 Ci/ml; MP Bio-
medicals, Irvine, CA). After the label, cells were washed 3 times
with 3 ml of ice-cold PBS, and surface proteins were biotiny-
lated by the addition of 1 mg/ml EZ-Link Sulfo-NSH-Biotin
(Pierce; in PBS) rocking for 35 min at 4 °C followed by incuba-
tion at room temperature for 15min. Cells were thenwashed an
additional 3 times with ice-cold PBS and lysed with 500 l of
radioimmunoprecipitation assay lysis buffer (100mMTris-HCl,
pH 7.4, 150 mM NaCl, 0.1% SDS, 1% Triton X-100, 1% deoxy-
cholic acid, 1 mM phenylmethylsulfonyl fluoride (Sigma), 25
mM iodoacetaminde (Sigma), and 1 kallikrein inhibitory unit of
aprotinin (Calbiochem)). The cellular lysate was centrifuged at
136,500 g for 15min at 4 °C. The supernatant was removed to
a 1.5-ml microcentrifuge tube, and 4 l of Hendra F peptide
antibody was added and incubated for 3 h or overnight at 4 °C
followedby incubationwith 30l of ProteinA-Sepharose beads
(GE Healthcare) for 30 min. The beads were washed 2 with
radioimmunoprecipitation assay buffer 0.30MNaCl, 2with
radioimmunoprecipitation assay buffer 0.15 MNaCl, and 1
with SDS Wash II (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 2.5
mMEDTA).Once the beadswerewashed, 60l of 10% SDSwas
added, and the samples were boiled for 10 min, removed to a
new tube, and repeated with 40 l of 10% SDS for a total of 100
l. Ten microliters of the supernatant was removed to analyze
total population. To the remaining supernatant, 30 l of
Streptavidin beads (Pierce) and 400 l of biotinylation dilution
buffer (20 mM Tris (pH 8), 150 mM NaCl, 5 mM EDTA, 1%
TritonX-100, 0.2% bovine serum albumin) were then added for
1 h at 4 °C, rocking. Analysis ofHendra Fwas performed by 15%
SDS-PAGE and visualized using the Typhoon imaging system
(GE Healthcare). Band densitometry using ImageQuant 5.2
(GE Healthcare) was performed for each experiment to quan-
titate the amount of surface-expressed F1 present in each
sample. For the DN Rab5 and TPCK (N-tosyl-L-phenylalanine
chloromethyl ketone) trypsin experiments, Vero cells were
transfectedwith 1.5g of eitherwild-type ormutant pCAGGS-
Hendra F and 1.5 g of DN-Rab5, and the experiment was per-
formed as described above, except with the addition of 1g/ml
of TPCK-trypsin to the label media.
Luciferase Reporter Gene Assay—Vero cells in 6-well plates
were transiently transfected with 0.9g of wild-type pCAGGS-
Hendra G, 0.3 g of wild-type or mutant pCAGGS-Hendra F,
and 0.8 g of T7 luciferase under the control of the T7 pro-
moter (2 g total DNA) using Lipofectamine and Plus reagent
per the manufacturer’s protocol. Eighteen hours post-transfec-
tion, Vero cells were washed 1 with PBS and overlaid with
BSR cells (1:1) stably expressing the T7 polymerase for 3 h at
37 °C. Cells were lysed and assayed for luciferase activity using
the luciferase assay system from Promega (Madison, WI)
according to the manufacturer’s instructions. An Lmax lumi-
nometer (Molecular Devices, Sunnyvale, CA) was used to
measure light emission; a 2-s delay and 8-s read timewere used.
Values were normalized to samples containing wild-type
pCAGGS-Hendra F and G, with wild-type set at 100%, after
subtraction of the pCAGGS-Hendra G alone values.
Peptide Synthesis and Purification—Five peptides were used
in this study: guest, GCGKKKK; wild-type, LAGVVMAGI-
AIGIATA GCGKKKK; VM114/115AA; LAGVAAAGIAIGIA-
TAGCGKKKK; V114A, LAGVAMAGIAIGIATAGCGKKKK;
M115A, LAGVVAAGIAIGIATAGCGKKKK. This host guest
system was first described by Han and Tamm (16). Peptides
used in this study were obtained from either GenScript (Pisca-
taway,NJ) orNEO-Peptide (Cambridge,MA) andwere purified
to95% purity by reverse-phase HPLC, with peptide identities
confirmed by mass spectrometry. The C terminus of each pep-
tide was amidated, whereas the N terminus was unmodified.
Stock peptide solutions weremade by resuspending peptides in
sterile, deionizedwater, and amino acid analysis was performed
(W. M. Keck Foundation Biotechnology Resource Laboratory
at Yale University, New Haven, CT) to determine the concen-
trations of all stock solutions. Working stocks of 750 M in
sterile, deionized water were prepared, and all stock solutions
were stored as small aliquots and kept at20 °C.
Hemolysis Assay—Chicken red blood cells (RBCs) were pur-
chased from Innovative Research (Novi,MI) as a 5% v/v suspen-
sion in PBS and were used within 2 weeks of purchase. For the
hemolysis studies, chicken RBCs were diluted to 2% with PBS
immediately before use. The final reaction volume for each
sample was 300 l, consisting of 260 l of 2% chicken RBCs
and 40 l of either peptide, water, or a mixture of the 2 in a
1.5-ml centrifuge tube. Final peptide concentration was
between 0 and 100 M. Samples were incubated at 37 °C for
45 min and centrifuged at 3000  g, and supernatant was
removed to another tube. Absorbance of each sample was
then taken at 520 nmwith complete hemolysis obtained after
lysing chicken RBCs with 0.5% Triton X-100. Absorbance
values were then expressed as a percent of values obtained
from Triton X-100 lysis.
Micelle Preparation and Circular Dichroism (CD) Spec-
troscopy—Dodecylphosphocholine (DPC) micelles were pre-
pared 1 day before use by drying the DPC/chloroform solution
under a continuous nitrogen stream. Residual chloroform was
removed by placing the DPC sample under a vacuum for 30
min. Dried DPC was then resuspended in 5 mMHEPES, 10 mM
MES buffer (pH 7.4) by gently shaking for 20 min and then
stored at 4 °Cuntil use the nextmorning. For experiments using
different peptide:DPC ratios, separate micelle preparations
weremade for each ratio. Circular dichroism (CD) spectra were
measured with a Jasco J-810 spectrapolarimeter using a quartz
cuvette with a 1-mm path length. All measurements were per-
formed at 22 °C, and each spectrum is an average of 4 scanswith
3 independent spectra taken for each sample. Spectra were
measured in 5 mM HEPES, 10 mM MES buffer (pH 7.4) plus or
Hendra F Fusion Peptide andMembrane Fusion
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minus 10 mM DPC (Avanti Polar Lipids, Alabaster, AL) with
peptide concentrations of 100M (peptide:DPC ratio of 1:100).
Background spectra without peptide were collected and sub-
tracted from spectra taken in the presence of peptide. Estima-
tion of the fraction of residues in -helical formation was per-
formed as previously described (36). CD spectra using small
unilamellar vesicles (SUVs) spectra were acquired on an Aviv
model 215 spectropolarimeter in a 0.5-mm quartz cell at 22 °C.
Data were collected from 200–260 nm. Experiments were col-
lected with 100 M peptide in 5 mM Hepes, 10 mM MES buffer
with and without 5 mM POPC:POPG SUVs.
Preparation of SUVs—Appropriate amounts of stock POPC
and POPG in chloroform were mixed and evaporated to a film
with a nitrogen stream. The films were hydrated with 5 mM
Hepes 10 mM MES buffer and sonicated with a Branson ultra-
sonicator equipped with a titanium tip on ice until the vesicle
solution became clear. Titanium particles were removed by
centrifugation.
Preparation of Supported Bilayers—Planar single bilayers
were prepared using a Langmuir trough. A monolayer of 1,2-
dimyristoyl-sn-glycero-3-phosphocholine was spread on the
trough. A germanium attenuated total reflectance (ATR)-IR
platewas dipped into the trough and slowly removed to transfer
a single 1,2-dimyristoyl-sn-glycero-3-phosphocholine mono-
layer. To form the second lipid leaflet, the plate was incubated
with SUVs composed of POPC:POPG95:5 in a chamber for 1–2
h. Excess vesicles were washed away with 2 ml of D2O buffer
(37, 38).
ATR-Fourier Transform Infrared Spectroscopy (ATR-FTIR)—
Measurements were collected using a Bruker Vector 22 Fourier
transform infrared spectrometer equipped with an ATR-IR
accessory. Before bilayer formation, parallel- and perpendicu-
lar-polarized attenuated total reflection measurements were
obtained for the bare germanium plate in D2O buffered with 5
mMHepes, 10 mMMES containing 150 mMNaCl. These meas-
urements were used as references to calculate absorbance spec-
tra of the parallel and perpendicular data collected with the
single bilayer formed on the germanium plate. Dichroic ratios,
RATR, were determined for the characteristic lipid methylene
stretching bands at 2920 and 2850 cm1. Lipid order parame-
ters, SL, were calculated using the equation (38),
SL  2
Ex
2 RATREy
2 Ez
2
Ex
2 RATREy
2 Ez
2 (Eq. 1)
where Ey2, Ex2, and Ez2 are 1.9691, 2.2486, and 1.8917, respectively
(37, 38). SL can range from 0 to 1, and lower values for SL
represent more disordered lipids.
RESULTS
Alanine Substitution at GV112/113 andG117 Results in Pro-
tein Misfolding and Inefficient Cathepsin L Processing—Previ-
ous studies on paramyxovirus FPs have largely focused on con-
served glycine residues within this region (31–34). To examine
the possible role of surrounding amino acids in fusion, scanning
alaninemutagenesiswas performed, resulting in four F proteins
with either single or double alanine mutations (Fig. 2A). Before
examining the fusogenicity of the mutant proteins, cell surface
biotinylation was performed to ensure that they were properly
folded, transported to the cell surface, and had undergone pro-
teolytic processing by cathepsin L. Vero cells transfected with
either wild-type or mutant F proteins were metabolically
labeled, and cell surface proteins were biotinylated followed by
immunoprecipitation, separation of biotinylated F proteins,
and analysis by SDS-PAGE. Alanine substitution of either L110
or VM114/115 did not disrupt protein folding as both mutant
proteins were expressed at or above wild-type levels (Fig. 2B).
Mutation of GV112/113 to alanine significantly reduced cell
surface expression (CSE) levels, as compared with wild-type,
whereas the G117A mutant failed to undergo proteolytic
processing, suggestive of protein misfolding. As cathepsin
L-mediated cleavage of Hendra F occurs directly N-terminal
to the FP, cleavage efficiency was calculated by band densi-
tometry (F1/(F1 F0))) to determine if mutations within the
fusion peptide affect cleavage. Both L110A F and VM114/
115AA F were cleaved (62.5  3.4 and 65.6  1.8%, respec-
tively) at wild-type levels (67.5  4.8%), demonstrating that
mutation of these residues did not affect efficiency of cathep-
sin L processing. Cleavage efficiency of GV112/113AA F was
reduced to approximately two-thirds of wild-type levels
(40.2 6.5%), whereas G117A F was minimally processed by
cathepsin L (14.3  5.7%), suggesting that glycine substitu-
tions result in either a misfolded protein with altered cleav-
age site accessibility or modulate critical interactions with
cathepsin L needed for cleavage.
Unlike other paramyxovirus F proteins, Hendra F is initially
surface-expressed in a non-fusogenic F0 form, which is then
endocytosed and subsequently cleaved after residue Lys-109 by
cathepsin L into the fusogenically active F1F2 form (39–42).
As an alternative to cathepsin L, cell surface-expressed F0 can
be efficiently cleaved into F1F2 by the addition of exogenous
TPCK-trypsin, so susceptibility to TPCK-trypsin cleavage can
be used to differentiate between the above hypotheses (43). To
more clearly observe changes in F cleavage, uncleaved F0 was
blocked at the cell surface by co-transfection with a dominant-
negative form of Rab5 (DN-Rab5), a small GTPase required for
endocytosis (44). Human metapneumovirus F, which can be
cleaved extracellularly by trypsin (45, 46), was used as a positive
control and is efficiently cleaved by addition of TPCK-trypsin
(Fig. 2C). In the absence of DN-Rab5, a slight increase in wild-
type F1 was observed upon the addition of TPCK-trypsin (Fig.
2C). Co-transfection ofDN-Rab5 to blockwild-type F at the cell
surface followed by exogenous TPCK-trypsin cleavage led to a
large increase in F1 (Fig. 2C). Whereas cell-surface F0 is
increased in the presence of DN-Rab5 for GV112/113AA F
addition of TPCK-trypsin led to a significant reduction of F0
(Fig. 2C) for GV112/113AAFwith no noticeable increase in the
cleaved F1 form. Furthermore, the decrease in F0 upon the addi-
tion of TPCK-trypsin observed for GV112/113AA indicates
that these mutations likely expose additional TPCK-trypsin
cleavage sites, suggestive of a looser overall protein fold. No
increase in either F0 or F1was observed forG117AuponTPCK-
trypsin treatment suggestive of protein misfolding. These data
suggest that the GV112/113AA mutations result in misfolding
of the cleavage site, rendering it only partially accessible
Hendra F Fusion Peptide andMembrane Fusion
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(GV112/113AA) or completely inaccessible (G117A) to
TPCK-trypsin.
VM114/115AA F Does Not Promote Membrane Fusion
DespiteWild-type Surface Expression Levels—Co-expression of
Hendra F along with its homotypic attachment (G) protein is
sufficient to induce cell-cell fusion, so syncytia formation can
be used to directly assess F protein fusogenicity. 24–36 h post-
transfection, Vero cells expressing wild-type Hendra F and G
formed large syncytia, whereas expression of G alone was not
sufficient for syncytia formation (Fig. 3A). Syncytia formation
for L110A Fwas slightly reduced fromwild-type levels, whereas
GV112/113AA F and G117A showed little syncytia formation,
consistent with reduced surface expression levels of the cleaved
fusogenically active form. Surprisingly, the mutant VM114/
115AA F could not promote syncytia formation despite being
surface-expressed above wild-type levels.
For a more quantitative measure of F-mediated cell-cell
fusion, a luciferase reporter gene assay was performed. Vero
cells transfected with wild-type or mutant Hendra F and wild-
type G along with a plasmid containing the luciferase gene
under the control of the T7 promoter were overlaid with BSR
cells, which stably express the T7 polymerase. Cell-cell fusion
allows for expression of luciferase, thus providing a quantitative
measure of cell-cell fusion. Consistent with the syncytia data,
L110A F promoted fusion at slightly reduced levels (65.4 
9.6%), whereas cell-cell fusion promoted by GV112/113AA F
and G117A F was extremely low and proportional with F1 cell-
surface expression (Fig. 3B). No fusion was observed for
VM114/115AA, clearly demonstrating thatmutation of both of
these residues together dramatically affects F-promoted mem-
brane fusion without altering protein expression or cathepsin L
processing.
Peptides Corresponding to the VM114/115AA FP Do Not
Cause Efficient Hemolysis—Viral fusion peptides have been
hypothesized to play a major role in driving membrane fusion
through modulation of membrane curvature and lipid organi-
zation of the target cell membrane (6, 10). Thus the VM114/
115AA mutation could potentially alter the ability of the FP to
interact with and insert into the target cell membrane after
triggering of F. To examine potential changes in membrane
interactions, synthetic peptides corresponding to the first 16
amino acids of the FP (guest) for both wild-type and VM114/
115AA F were designed coupled to a highly charged, flexible
host peptide (Fig. 4A). Previous work studying influenza HA
has extensively characterized the biophysical properties of this
host-guest system and has shown that these peptides are highly
water-soluble and remain monomeric in low ionic strength
solutions (16, 36). Synthetic FPs have also been shown to cause
RBC lysis (hemolysis) (16), and the degree of hemolysis can be
used to assay changes in the extent or nature of FP-membrane
interactions. Chicken RBCs were incubated with increasing
concentrations of either guest, wild-type, or VM114/115AA
peptide, the supernatant was clarified through centrifugation,
and hemolysis was assayed by measuring the absorbance of
hemoglobin at 520 nm. Maximum hemolysis was defined by
incubating RBCs with 0.5% Triton X-100, and all subsequent
FIGURE 2. Cell-surface expression of Hendra F fusion peptide mutants. A, Alignment of Hendra F FP mutants is shown. CTD, C-terminal domain.
B, cell-surface expression of FP mutants is shown. After transfection with empty pCAGGS vector or either wild-type or mutant pCAGGS-Hendra F, cells were
starved and labeled with Tran35S-label containing Cys/Met, and surface proteins were biotinylated. After cell lysis, Hendra F was immunoprecipitated, and
surface proteins were pulled down with Streptavidin beads. Protein was analyzed via 15% SDS-PAGE, and bands were visualized using the Typhoon imaging
system. C, exogenous TPCK-trypsin cleavage of surface-expressed wild-type or mutant F proteins in the presence or absence of dominant negative Rab5
(DN-Rab5) is shown.Humanmetapneumovirus F (HMPVF)was used as apositive control for TPCK-trypsin cleavage andactivity. BothB andC are representative
gels from one of three independent experiments.
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absorbance values were expressed as a percentage of this max-
imum. Host peptide alone at concentrations up to 100 M was
unable to cause significant levels of hemolysis (Fig. 4B, circle),
whereas wild-type peptide (Fig. 4B, square) resulted in a con-
centration-dependent increase in hemolysis with a maximum
value of 56.1%6.9. Incubation with VM114/115AA peptide
(Fig. 4B, diamond) resulted in a 75% reduction of hemolysis
(18.0 0.9%) demonstrating that mutations at these positions
affect either the ability of the peptide to interact with mem-
brane or, more likely, change the nature of this membrane
interaction.
VM114/115AA Peptide in Detergent Micelles Is Significantly
Less -Helical Than the Wild-type Peptide—Previous studies
(for review, see Ref. 15) in other viral systems suggested that
-helical structure in at least a part of the FP correlates with
fusion (47). The FP of influenza HA adopts a boomerang-like
shape within model membranes, and point mutations that dis-
rupt this structure abolish or reduce HA-mediated membrane
fusion in the context of the whole protein (17, 18, 27). Thus, the
lack of membrane fusion promotion and the significantly
reduced hemolysis observed for VM114/115AA F could be a
result of altered secondary structure within membranes. To
examine this possibility, CD spectra were obtained for the host,
wild type, and VM114/115AA peptides in the presence or
absence of DPCmicelles, used tomimic the hydrophobicmem-
brane environment. DPC micelles appropriately mimicked a
membranous environment, as subsequent experiments using
POPC:POPG SUVs provided similar results (see Fig. 7). In
aqueous solution all three peptides were disordered (Fig. 4C).
The addition of 10mMDPC (1:100 peptide:DPC ratio) caused a
large structural change in both the WT and VM114/115AA
peptides resulting in more ordered and partially -helical con-
FIGURE 3. Fusogenicity of wild-type and mutant Hendra F proteins. A, syncytia assays demonstrating cell-cell fusion promotion of wild-type or mutant F
proteins in the presence of the Hendra attachment (G) protein are shown. Vero cells transfected with either empty pCAGGS andwild-type pCAGGS-Hendra G
or wild-type or mutant pCAGGS-Hendra F and wild-type pCAGGS-Hendra G were monitored for syncytia formation as described under “Experimental Proce-
dures.” 36–48 h after transfection, 10 images from different fields were taken using a Nikon Coolpix995 camera mounted on a Nikon TS100 inverted phase-
contrast microscope. Representative images are shown from one of three independent experiments. B, quantitative luciferase reporter gene assays show
cell-cell fusion levels (black bars) alongside quantitation of F1 CSE levels fromFig. 2B. Band densitometrywas performedusing ImageQuant 5.2 (GEHealthcare)
software. Vero cells were transfected with a T7 luciferase construct and either empty pCAGGS and wild-type pCAGGS-Hendra G or wild-type or mutant
pCAGGS-Hendra F andwild-type pCAGGS-HendraG at a 1:3 F:G ratio as described under “Experimental Procedures.” 18–24 hpost-transfection Vero cellswere
overlaid with BSR cells stably expressing the T7 polymerase, cells were incubated for 3 h at 37 °C and lysed, and luciferase activity was measured. All data are
presented as the means S.E. for at least three independent experiments.
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formations (Fig. 4D). Interestingly, the wild-type (solid black
line) and VM114/115AA spectra were considerably different
from one another, demonstrating that alanine substitution at
positions 114/115 resulted in structural changes within amem-
brane-mimicking environment. To more clearly differentiate
between these two spectra, the -helical content of small pep-
tides can be approximated using the signal at 222 nm (222),
which is predominately due to the presence of -helical struc-
ture (36).Wild-type peptide has an estimated -helical content
of 35.8  0.1%, whereas the VM114/115AA peptide has one-
third less -helical character (24.6  0.4%) (Fig. 4D and Table
1). These data suggest that the wild-type Hendra F FP requires
a certain degree of -helical structure to drive efficient mem-
brane fusion.
Mutation of G112 to Alanine Is Responsible for the Decreased
Surface Expression of GV112/113AA—As the lack of fusion
observed for VM114/115AA could be due tomutation of either
or both of the two residues,mutant F proteins containing single
point mutations of residues 112–115 were generated (Fig. 5A).
All single alanine mutants were surface-expressed and proteo-
lytically processed (Fig. 5B), as expected based on the double
alaninemutant data. Three singlemutants, V113A, V114A, and
M115A, were expressed at or above wild type, whereas G112A
was expressed at approximately one-third of wild-type levels
(Fig. 5B). Cleavage efficiency for V113A, V114A, and M115A
was very similar to wild-type (64.1 6.9, 70.3 4.6, and 67.0
2.1%, respectively, compared with 67.5  4.8%), whereas
G112A was less efficiently cleaved (43.4  11.6%). Together,
these results demonstrate that mutation of G112 to alanine is
sufficient to dramatically reduce F surface expression levels
likely by misfolding portions of the protein.
Valine Residues within the Hendra F FP Are Important for
Membrane Fusion—Once surface expression levels were deter-
mined for the four single alaninemutants, syncytia and reporter
gene assays were performed to determine fusogenicity of
these mutant F proteins. Additionally, to further examine the
sequence requirements at G112, an additional mutation
(G112P) was made. A proline side chain is considerably larger
than glycine and should render this region considerably less
flexible. Unlike the two double mutants GV112/113AA and
VM114/115AA, all single alanine mutants promoted some
degree of syncytia formation (Fig. 6A). Cell-cell fusion levels for
M115A were close to wild type, whereas G112A, V113A, and
V114A showed reduced fusion. Quantitative reporter gene
analysis for these four mutants was consistent with data from
the syncytia assays, as M115A promoted cell-cell fusion at
almost wild-type levels (88.0  2.6%), whereas the remaining
three mutants had lower cell-cell fusion levels (Fig. 6B). Com-
parison of cell-cell fusion levels with F1 CSE reveals that only
V113A and V114A are impaired for fusion, as both G112A and
M115A promote fusion at levels consistent with CSE data. Sur-
prisingly, the G112P mutation increased CSE levels as com-
pared with wild-type and G112A (Fig. 6C). Cathepsin L proc-
essing of G112P was also higher (79.9  2.1% compared with
the wild-type value of 67.5 4.9). G112Pwas severely impaired
for cell-cell fusion promotion (Fig. 6C; 15.3  0.6%) as com-
pared with wild type. These data demonstrate that the combi-
nation of at least two single alaninemutations at theN terminus
of the FP can lead to dramatic fusion defects, whereas the single
mutants are better tolerated. Furthermore, these data indicate
that valine residues within the FP are essential for efficient
FIGURE 4. Hemolytic ability and CD spectra of synthetic fusion peptides.
A, shown are synthesizedpeptideswhere the first 16 amino acids of the FP for
either wild-type or mutant Hendra F are coupled to a flexible highly charged
host peptide. B, hemolytic ability of synthetic fusion peptides is shown.
Chicken RBCs were incubated with increasing concentrations of peptide for
45minat 37 °C. Supernatantswere thenclearedbycentrifugationat 11,000
g, and absorbance was measured at 520 nm. All values are expressed as a
percent of maximum hemolysis determined by RBC lysis with 0.5% Triton
X-100. Data are presented as themeans S.E. for at least three independent
experiments. C, CD spectra of all five peptides in the absence of DPC in 5 mM
Hepes, 10 mMMES pH 7.4 with peptide concentrations of 100 M are shown.
D, shown are spectra in the presence of 10 mM DPC micelles prepared in the
above buffer as described under “Experimental Procedures.” Spectra in both
C and D are representative of one of three independent experiments where
each spectrum is an average of four scans.
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membrane fusion promotion, whereas N-terminal glycine res-
idues are important for maintaining F protein stability and
proper folding.
V114A and M115A F Promote Hemolysis More Efficiently
Than the V114/115AA Double Mutant—As V114A and
M115A had increased levels of cell-cell fusion over the corre-
sponding double mutant, RBC hemolysis was performed as
described above using synthetic peptides corresponding to the
first 16 amino acids of the V114A andM115A FPs (Fig. 4A). Both
the V114A andM115A peptides were able to efficiently promote
hemolysis, at65–70% of wild type (Fig. 4B). As fusion levels for
V114A were lower than hemolysis levels as compared with wild
type, this suggests that the ability to disrupt membranes is neces-
sary but not sufficient for efficient membrane fusion.
Percentage of -Helical Structure in Synthetic Peptides Cor-
relates with Membrane Fusion Levels—Circular dichroism
spectra of peptides containing either the V114A and Met-115
mutations in the absence of DPC were largely disordered, sim-
ilar to theVM114/115AA spectrum (Fig. 4C). In the presence of
10 mM DPC, both the V114A and M115A peptides adopted
ordered secondary structures with considerable amounts of
-helicity (Fig. 4D). Surprisingly, theM115A peptide adopted a
conformation distinct fromwild type despite promoting almost
wild-type levels of cell-cell fusion within the context of the
whole protein. The V114A peptide adopted a conformation
similar to VM114/115AA, suggesting that the V114A substitu-
tion was the dominant determinant of peptide structure (Fig.
4D). Comparing these spectra with those of wild-type and
VM114/115AA reveals a strong correlation between estimated
peptide -helical content and fusogenicity (Table 1). The dif-
ference in -helical content between the VM114/115AA pep-
tide and the wild-type peptide is estimated to be around 10%
(24.6  0.4 and 35.8  0.1%, respectively). As V114A is esti-
mated to be around 24.6 0.4% helical, these data suggest that
decreases in peptide -helical content can dramatically affect
membrane fusion promotion.
Synthetic Fusion Peptide -Helicity Directly Correlates to the
Degree of Membrane Disordering—One way in which fusion
peptides are thought to help drive cell-cell and virus-cell mem-
brane fusion is through disordering of the target cell mem-
brane. Before examining peptide-induced membrane dis-
ordering, CD spectra of each synthetic fusion peptide were
determined in the presence of SUVs to ensure similar second-
ary structures in lipid bilayers as in detergent micelles. Vesicles
composed of bothPOPCandPOPGwere prepared as described
under “Experimental Procedures.” Little structural change was
observed for the wild-type peptide in pure POPC SUVs; how-
ever, the addition of peptide to SUVs containing 5–8% POPG
resulted in a dramatic shift to a predominately -helical struc-
ture (Fig. 7A), presumably because the presence of the nega-
tively charged lipids facilitated peptide binding through the
tetralysinemotif. All peptides were disordered in the absence of
SUVs (Fig. 7B) but exhibited high degrees of -helical structure
in the presence of SUVs (Fig. 7C), similar to spectra taken in
DPC. Thus, these data demonstrate that DPC is an acceptable
membrane mimic and confirm that the Hendra F FP adopts an
-helical structure in membranes.
TABLE 1
Data summary for transiently expressed F protein and synthetic FPs
All errors are reported as S.E. ND, not determined.
Fusion/F1 CSEa Cleavage Hemolysis -Helicity
% % % %
WT 100.0 0.0 67.5 4.8 56.1 6.9 35.8 0.1
L110A 48.8 13.6 62.5 3.4 ND ND
GV112/113AA 32.1 4.3 40.2 6.5 ND ND
G112A 98.5 30.5 43.4 5.8 ND ND
G112P 6.0 1.4 79.9 2.1 ND ND
V113A 54.9 17.3 64.1 3.4 ND ND
VM114/115AA 3.1 1.7 65.6 1.8 18.0 1.0 24.6 0.4
V114A 30.7 7.1 70.3 2.3 36.5 3.9 28.7 0.2
M115A 88.8 17.2 67.0 1.0 38.0 4.3 38.8 0.5
G117A 37.4 22.3 14.4 5.7 ND ND
a Cell-cell fusion values normalized to F CSE with propagated S.E.
FIGURE 5. Cell-surface expression of single alanine FP mutants. A, align-
ment of the four single alanine FPmutants is shown. B, cell-surface biotinyla-
tion of the four single alanine mutants performed as described in Fig. 2 and
under “Experimental Procedures” is shown. These lanes are from the samegel
as Fig. 2, thus allowing for a direct comparison between mutants. This is a
representative gel fromoneof three independent experiments.CTD, C-termi-
nal domain.
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To examine if membrane disordering is impaired by the
VM114/115AA or individual single mutations, ATR-FTIR
experiments were performed on peptides bound to single pla-
nar bilayers. The degree of lipid acyl chain order, denoted as SL,
can be determined by monitoring the dichroism of two promi-
nent absorption bands at 2920 and 2850 cm1 (38). Spectra
were collected with perpendicular- and parallel-polarized light,
and the dichroic ratios (RATR) of each peak were determined.
These ratios were then used to calculate the overall order of the
membrane (Equation 1 under “Experimental Procedures”). In
Fig. 8, the lipid order results are presented for a single planar
bilayer system before and after incubation with the synthetic
Hendra F fusion peptides. After incubation, the fusion-compe-
tent wild-type FP readily destabilized the bilayer. Interestingly,
the magnitude of membrane disordering correlated with the
degree of peptide-helical structure (in bothDPCmicelles and
POPC:POPGSUVs) andwith their fusion activity (Fig. 8). Thus,
the fusion defects observed for the V11A and VM114/115AA
mutants might be caused by an inability to drive sufficient mem-
brane disordering due to less -helical secondary structure.
Increased Effective Concentrations of VM114/115AA and
Wild-type Peptides Show Different Higher-ordered Structures—
As fusion peptide self-association has been hypothesized to
provide a mechanism of recruitment of multiple F proteins to
the site of fusion and in fusion pore formation (10, 15, 36, 48),
CD spectra of both wild-type and VM114/115AA peptide were
obtained under conditions that increased the effective peptide
concentration. Increasing or decreasing the concentration of
DPC (criticalmicelle concentration (CMC) of 1.1mM), whereas
keeping the peptide concentration at 100 M will either
decrease or increase the effective peptide concentration. Pep-
tide to DPC ratios of 1:100 or lower resulted in no significant
change in peptide secondary structure, suggesting that the
spectra obtained at these ratios was of mostly monomeric pep-
tide in solution (Fig. 9). As the effective peptide concentration
was increased (peptide:DPC ratios from 1:100 to 1:25), wild-
type peptide showed a dramatic shift to a predominately
-sheet structure (Fig. 9A). Surprisingly, at these same ratios,
the VM114/115AA peptide failed to exhibit this dramatic
structural shift, maintaining at least some degree of -helical
structure even at a peptide to DPC ratio of 1:25 (Fig. 9B). Com-
bined, these data suggest that mutation of VM114/115AA to
alanine affects the ability of themutant peptides to self-interact
or alters the higher order structure adopted upon FP
self-interaction.
DISCUSSION
Fusion peptides of enveloped virus fusion proteins serve
multiple functions throughout the fusion process (10, 49). Early
studies on viral FPs demonstrated that these domains can act as
FIGURE 6. Fusogenicity of wild-type and single alaninemutant F proteins. A, shown is a syncytia assay for each of the fourmutants as comparedwith wild
type. The experiment was performed as described in Fig. 3A and under “Experimental Procedures.” Images are representative of one of three independent
experiments. B and C, shown is a quantitative reporter gene analysis and quantitation of F1 cell-surface expression for FPmutants as comparedwithwild-type
F performed as described in Fig. 3B and under “Experimental Procedures.” All data are presented as the means  S.E. for at least three independent
experiments.
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membrane anchors and thus have the ability to stably insert
into and associate with membranes (50). Synthetic peptides
corresponding to wild-type or mutant FP sequences have been
used for structure determination in addition to liposome bind-
ing and fusion experiments, providing further evidence that
these domains participate inmembranemerger (14, 18, 25–27).
Although a wealth of data exists on the FPs of HIV Env and
influenza HA, little is known about the structure of paramyxo-
virus FPs in a membrane environment and whether particular
amino acids within these domains are critical for fusion. Data
presented here demonstrate that glycine residues within the FP
are important for efficient expression and processing of HeV F.
Furthermore, these data indicate that valine residues within the
FP are key modulators of F-mediated membrane fusion, most
likely by affecting the membrane-bound structure of the FP.
This study also demonstrates that altering the-helical second-
ary structure of the HeV F FP within a hydrophobic environ-
ment dramatically reduces membrane fusion, potentially
through two mechanisms: reduced membrane disordering and
altered FP-FP association.
Conserved glycine residues within viral FPs have been shown
to be key modulators of membrane fusion, and our data dem-
onstrate a role for FP glycine residues in F protein folding and
FIGURE 7. CD spectra of synthetic fusion peptides in POPG:POPG SUVs.
A, shown are CD spectra of wild-type Hendra F fusion peptides in the pres-
enceor absenceof SUVs composedofdifferingPOPC:POPG ratios.BandC, CD
spectra of wild-type and mutant Hendra F fusion peptides in the absence (B)
or presence (C) of POPC:POPG 95:5 SUVs are shown. Spectra were obtained
using a peptide concentration of 100 M in solution or with 5 mM SUVs com-
posed of POPC 100% or POPC:POPG 98:2, 95:5, and 92:8. All spectra were
recordedat 222 °C in a 0.5-mmquartz cuvette. Spectrawereobtained from
two independent sets of SUVs where each spectrum is an average of five
scans.
FIGURE 8. Peptide-induced membrane disordering obtained using ATR-
FTIR. A, lipid order parameters, SL, obtained for single planar bilayers before
and after incubation with 100 M Hendra WT, M115A, and VM114/115AA
peptides are shown. B, ATRdichroic ratios of lipidmethylene stretching vibra-
tions andderived acyl chain order parameters in the absence andpresence of
wild-type or mutant Hendra F fusion peptides are shown. For all cases the
bottom layer of the bilayer was composed of 1,2-dimyristoyl-sn-glycero-3-
phosphocholine, and the topwas formedwith POPC:POPG95:5. Experiments
were performed in D2O buffered with 5 mM HEPES and 10 mM MES with 150
mM NaCl. Data represent two independent bilayer preparations for each
peptide.
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stability. Failure of exogenous TPCK-trypsin cleavage in the
presence of DN-Rab5 to significantly increase the amount of F1
on the surface for either GV112/113AAorG112A suggests that
the G112A mutation results in misfolding around the cleavage
site (Fig. 2C). Surprisingly, G112P drastically decreased cell-cell
fusion despite greater-than-wild-type CSE and processing lev-
els (Fig. 6C). Proline is strongly disruptive of -helix and
-sheet in globular proteins; however, studies usingmodel pep-
tides demonstrate that proline has a helical propensity near that
of alanine within a membrane-mimicking environment (51).
Glycine, also a potent helix-breaker in globular proteins, pro-
motes -helix formation to a similar extent as alanine in a
membrane environment (52–54). Given the similar helical pro-
pensities of alanine and proline in membranes, G112P might
not affect the conformation of the FP once inserted into mem-
branes butmight increase the stability of the protein such that it
is not triggered effectively, as proline has been shown to
increase the thermostability of proteins in certain contexts (55).
Mutation of amore C-terminal glycine, G117, to alanine results
in inefficient protein expression and cathepsin L processing
(Fig. 2B), and G117A is unable to be cleaved by exogenous
TPCK-trypsin (Fig. 2C), starkly contrasting with identical
mutations inHPIV3 andNDVF. Furthermore, the correspond-
ing mutation in PIV5 F (G7A) increased membrane fusion to
approximately 4 times that of wild type while reducing CSE
to about 20% (33). Together these data point toward a model
in which residues within the FP can modulate protein stabil-
ity and/or folding. Similarly, previous work with Hendra F
(56) suggested that side-chain packing beneath the fusion
peptide can act in regulation of F protein triggering and the
final extent of fusion. Ultimately, the phenotypic differences
between glycine mutants of HeV, NDV, PIV5, and HPIV3 F
underscore the essential linkage between proper folding of
the prefusion metastable F protein and efficient membrane
fusion promotion.
Aside from glycine residues, little is known about the role of
other amino acids present within the FP in regulating mem-
brane fusion. For all paramyxovirus FPs, the N-terminal amino
acid has a large, hydrophobic side chain, typically a phenylala-
nine or leucine.Mutation of the first FP residue inHeV F, L110,
to alanine reduced cell-cell fusion to 60–65% that of wild-type
levels without altering CSE levels (Fig. 3B), indicating the slight
preference for a large, hydrophobic residue in this position.
Because both leucine and phenylalanine (57) at position 110 are
fusion-competent, substitution with an alanine might decrease
membrane interaction or alter depth or angle of membrane
insertion as this would substantially reduce the hydrophobicity
of the N terminus of the FP. Fitting with this idea, mutation of
the N-terminal glycine (Gly-1) within the influenza HA FP to
residues other than alanine significantly impaired membrane
fusion (58); thus FPs from various viruses seem to have strict
requirements for the N-terminal residue. The fact that the
chemical properties (large and hydrophobic for the paramyxo-
viruses, versus small and aliphatic for influenza) of the N-ter-
minal residue differ dramatically suggests that despite perform-
ing almost identical biological functions, viral families have
evolved distinct FP structures all able to efficiently catalyze
membrane fusion.
Data presented here also demonstrate that valine residues
are critical in F-mediated membrane fusion. Cell-cell fusion
assays show that the GV112/113AA and VM114/115AA
mutants were defective for fusion, as bothmutant proteins pro-
moted membrane fusion at levels below what was expected
based on CSE (Fig. 3B). Generation of the single mutants
G112A, V113A, V114A, and M115A strongly indicate that the
valine to alanine substitutions were largely responsible for the
decreases in fusion, as both G112A and M115A drove mem-
brane fusion at levels expected based on CSE (Fig. 6B).
Although this phenotype could result from stabilization of the
pre-fusion structure, the position of these mutations suggest
that the reduction in fusion may be due to alterations in the
ability of the FP to disrupt membranes and/or the membrane-
induced secondary structure. Hemolysis data indicate that the
VM114/115AA peptide had a significantly reduced ability to
disrupt membranes as compared with wild type (Fig. 4B),
whereas similar experiments on the two singlemutants, V114A
and M115A, show almost identical hemolytic tendencies (Fig.
4B). Such a disconnect between hemolytic ability and fusoge-
nicity for the V114A and M115A peptides suggest that,
although the ability of synthetic peptides to disruptmembranes
often correlates with the fusogenicity of the full-length protein,
membrane disruption alone is not sufficient for fusion.
Circular dichroism spectra of the synthetic FPs in DPC
micelles show that substitution of valine with alanine signifi-
FIGURE 9. Dependence of peptide secondary structure on effective pep-
tide concentration. A, CD spectra of wild-type peptide at various DPC con-
centrations are shown. B, CD spectra of VM114/115AApeptide at variousDPC
concentrations are shown. Spectra in both A and B are representative of one
of three independent experimentswhere each spectrum is an averageof four
scans.
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cantly decreases -helical content of the V114A peptide,
whereas theM115A peptide has wild-type levels of-helix (Fig.
4D). Although valine is typically thought of as a -sheet-pro-
moting residue in globular proteins, work by Deber and Li (52)
shows that valine promotes -helix formation to a stronger
degree than alanine in the context of membrane-mimicking
environments. Additionally, CD spectra of each of the peptides
in POPC:POPGSUVs also demonstrate that both of themutant
peptides, V114A and VM114/115AA, adopt a less -helical
structure (Fig. 7C). This observation is supported by other stud-
ies (for review, see Ref. 14, 49)) which suggest that the -helical
structure of FPs within model membranes correlates with
F-mediated membrane fusion promotion. Mechanistically, an
-helical FP structure could facilitate subsequent stages in
membrane fusion including changes within the target mem-
brane. Incubation of planar lipid bilayers with the wild-type
peptide increasedmembrane disorder (Fig. 8), whereas incuba-
tion with the non-fusogenic VM114/115AA peptide failed to
alter membrane ordering. Thus, these data provide a strong
correlation between cell-cell fusion levels and membrane dis-
ordering,where only the FPs from fusogenic F proteins cause an
increase in membrane disordering. Such a mechanism for FP
function fits very nicely within the context of the currently
accepted models for F-mediated membrane fusion, whereby
the FP is thought to insert into the target cell membrane, adopt
a specific secondary structure, and help to drive fusion between
both the cellular and viral membranes. An increase in mem-
brane disordering could presumably facilitate mixing between
both membranes and could also help drive the stalk-to-pore
transition.
In addition to changes in -helicity modulating membrane
fusion and disordering, mutations within the FP could affect
potential FP-FP or FP-TMD interactions. This is an appealing
hypothesis because the FPs of each F monomer are likely posi-
tioned in close proximity after extension of HRA. Furthermore,
the TMD and FP are positioned on the same end of the mole-
cule in the post-fusion structure of paramyxovirus F proteins.
Thus it is possible that both FP-FP and FP-TMD interactions
could regulatemembrane fusion.A recent report fromDegrado
and co-workers (48) demonstrated that synthetic FPs of PIV5 F
interact with one another in a reversible monomer-hexamer
equilibrium. Additionally, they also demonstrated interactions
between both isolated fusion peptides and transmembrane
domains, suggesting that these two domains might associate
later in the fusion process. Circular dichroism spectroscopy
with the host-guest system used in this study examined the
self-interaction of FPs over a range of solution ionic conditions
(36). In this study, Han and Tamm (36) demonstrated that in
low ionic strength solutions the synthetic FPsweremonomeric.
However, increasing the ionic strength of the solution led to
peptide self-aggregation on the surface of model membranes
and formation of an antiparallel -sheet structure. Similar
experiments, except by altering the peptide-to-lipid ratio on
both VM114/115AA and wild-type peptides, demonstrated
that the wild-type peptide quickly shifted to a predominately
-sheet structure as the effective peptide concentration was
increased (Fig. 9). Although there was a decrease in -helical
structure for the VM114/115AA peptide as the effective pep-
tide concentration was increased, the dramatic shift to -sheet
was absent. This lack of -sheet formation could be interpreted
in two ways; the VM114/115AA peptide self-interacts to a
lesser extent thanWT, or that upon interacting, these peptides
adopt a different higher-ordered structure. Ultimately, addi-
tional experiments (including mutagenesis of other branched
hydrophobic amino acids within the FP) will be needed to dis-
cern between these two hypotheses, but the data shown here
present amodel in which theHendra F FPmust adopt an-hel-
ical structure for efficientmembrane fusion promotion and tar-
get membrane disordering. Given the high sequence homology
to other paramyxovirus FPs, these data also suggest that an
-helical structure is a requirement for all paramyxovirus
F-mediated fusion and that mutations which alter this helicity
significantly decrease fusion.
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